Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: DETACT sEvere asThmAtiC paTients - a Pilot Study
Pilot study update for DETACT in severe asthma patients; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Effectiveness of Asthma Education Program Based on the Roy Adaptation Model [NA]
The clinical trial titled 'Effectiveness of Asthma Education Program Based on the Roy Adaptation Model' is a recruiting study evaluating an …
-
FDA approval · 2025-06-13FDA Approved: THEOPHYLLINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Theophylline submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Exploring Respiratory Health Outcomes From Sustained Use of Efficient Cookstoves [NA]
This clinical trial update investigates respiratory health outcomes associated with sustained use of efficient cookstoves, sponsored by Bost…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing [Phase 4]
Phase 4 clinical trial update on an innovative steroid treatment aimed at reducing asthma development in children after rhinovirus-induced w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE) [NA]
A clinical trial is recruiting to test a self-guided internet-based supportive intervention (SELF-BREATHE) intended to reduce chronic breath…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes [Phase 2]
Phase 2 clinical trial evaluating L-citrulline supplementation in overweight individuals with late-onset asthma phenotypes.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab [Phase 3]
A Phase 3 trial update evaluating whether house dust mite SLIT tablets can sustain asthma control in patients with severe asthma who are tre…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma [Phase 2]
Phase 2 clinical trial investigating anti-inflammatory lipid mediators for asthma. The study also includes obesity as a condition and is cur…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation
A child-inclusive translational study to develop and evaluate non-invasive, accessible tests for diagnosing asthma, with recruitment ongoing…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department [NA]
A clinical trial evaluating early high-flow oxygen therapy combined with a vibrating-mesh nebulized beta-2 agonist for moderate to severe as…
-
FDA approval · 2025-06-05FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) from Organon LLC. The approval upd…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adults With Mild Asthma. [Phase 1]
A Phase 1 pharmacokinetic and pharmacodynamic study of AZD4604 delivered via Turbuhaler in adults with mild asthma has been completed.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets) [Phase 3]
A Phase 3 trial evaluating budesonide/formoterol in combination with immune-modulating tablets (Staphylococcus and Neisseria) for asthma, cu…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: T2 Biomarkers Predictive Value in Occupational Asthma After Cessation of Exposure. [NA]
A clinical trial from University Hospital Strasbourg evaluating whether T2 inflammatory biomarkers can predict outcomes in occupational asth…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Wheeze Detection Using Aevice Medical Device
Clinical trial update reporting the completion of a study evaluating wheeze detection using the Aevice Medical Device. The study enrolled su…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers [Phase 3]
A Phase 3 trial evaluating vitamin D supplementation to prevent viral-induced asthma in preschoolers has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma [Phase 1]
Phase 1 study evaluating interferon gamma-primed mesenchymal stromal cells for moderate-to-severe persistent asthma has been terminated; the…
-
EMA approval · 2025-05-28EMA Authorised: Xolair (omalizumab) — Novartis Europharm Limited
The European Medicines Agency authorised Xolair (omalizumab) for asthma, urticaria, and rhinitis with Novartis Europharm Limited as the mark…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants [Phase 1]
Phase 1 study to evaluate safety and tolerability of multiple doses of IBI3002 in healthy and asthmatic participants; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype [Phase 2]
Phase 2 trial evaluating pharmacodynamic effects, efficacy and safety of SHR-1703 in asthma patients with eosinophilic phenotype has complet…
-
FDA label_change · 2025-05-22FDA Approved: EBGLYSS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for EBGLYSS (lebrikizumab-lbkz) from Eli Lilly, affecting the drug's label.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma
A clinical trial at the University of Kansas Medical Center is evaluating ventilation defects downstream of mucus plugs in patients with ast…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Azithromycin and Oesophageal Function in Respiratory Disease
A completed clinical trial evaluating the effect of azithromycin on esophageal function in individuals with respiratory conditions, includin…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Supporting Parents to Choose Wisely [NA]
A completed University of Alberta clinical trial evaluated decision-support tools to help parents choose care for children with several comm…